American Oncology Network, Inc. Quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest in USD from Q3 2023 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.
Summary
American Oncology Network, Inc. quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest history and growth rate from Q3 2023 to Q3 2024.
  • American Oncology Network, Inc. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest for the quarter ending September 30, 2024 was -$103M, a 69.9% increase year-over-year.
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Quarterly (USD)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 -$103M +$239M +69.9% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 -$39.5M Jun 30, 2024 10-Q 2024-11-13
Q1 2024 -$167M Mar 31, 2024 10-Q 2024-08-14
Q4 2023 -$161M Dec 31, 2023 10-Q 2024-11-13
Q3 2023 -$341M Sep 30, 2023 10-Q 2023-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.